PT1289364E - Gabapentina estavel contendo mais do que 20 ppm de iao cloreto - Google Patents
Gabapentina estavel contendo mais do que 20 ppm de iao cloretoInfo
- Publication number
- PT1289364E PT1289364E PT01946364T PT01946364T PT1289364E PT 1289364 E PT1289364 E PT 1289364E PT 01946364 T PT01946364 T PT 01946364T PT 01946364 T PT01946364 T PT 01946364T PT 1289364 E PT1289364 E PT 1289364E
- Authority
- PT
- Portugal
- Prior art keywords
- ppm
- chloride
- stable
- gabapentine
- iao
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21196700P | 2000-06-16 | 2000-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1289364E true PT1289364E (pt) | 2004-04-30 |
Family
ID=22788993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT01946364T PT1289364E (pt) | 2000-06-16 | 2001-06-15 | Gabapentina estavel contendo mais do que 20 ppm de iao cloreto |
Country Status (12)
Country | Link |
---|---|
US (1) | US6531509B2 (pt) |
EP (1) | EP1289364B1 (pt) |
AT (1) | ATE255891T1 (pt) |
AU (1) | AU2001268426A1 (pt) |
CA (1) | CA2410867C (pt) |
DE (2) | DE60101476T2 (pt) |
DK (1) | DK1289364T3 (pt) |
ES (1) | ES2193008T3 (pt) |
IL (1) | IL153398A0 (pt) |
PT (1) | PT1289364E (pt) |
TR (1) | TR200302296T4 (pt) |
WO (1) | WO2001097612A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060123782A (ko) * | 2000-06-16 | 2006-12-04 | 테바 파마슈티컬 인더스트리즈 리미티드 | 제어 범위 내의 ph를 갖는 안정한 가바펜틴 |
US7056951B2 (en) * | 2000-09-26 | 2006-06-06 | Mutual Pharmaceutical Co., Inc. | Stable solid dosage forms of amino acids and processes for producing same |
US7612112B2 (en) | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
US20030119908A1 (en) * | 2001-12-21 | 2003-06-26 | Zambon Group S.P.A. | Stable gabapentin compositions |
AU2003301184A1 (en) * | 2002-12-20 | 2004-07-22 | Dynogen Pharmaceuticals Inc | METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING Alpha2Delta SUBUNIT CALCIUM CHANNEL MODULATORS |
BRPI0408608A (pt) * | 2003-03-21 | 2006-03-07 | Dynogen Pharmaceuticals Inc | uso de moduladores da subunidade (alfa)2(delta) de canal de cálcio e moduladores de músculo liso para tratamento de sintoma de um distúrbio do trato urinário inferior |
WO2005046566A2 (en) * | 2003-08-04 | 2005-05-26 | Sun Pharmaceutical Industries Limited | Stable gabapentin containing composition |
KR20060109922A (ko) * | 2003-10-31 | 2006-10-23 | 알자 코포레이션 | 가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형 |
US20050187295A1 (en) * | 2004-02-19 | 2005-08-25 | Surendra Kalyan | Processes for the preparation of gabapentin |
US20070092565A1 (en) * | 2005-10-25 | 2007-04-26 | Pharmascience Inc. | Gastric retention drug delivery system |
NL2000281C2 (nl) | 2005-11-02 | 2007-08-07 | Pfizer Prod Inc | Vaste farmaceutische samenstellingen die pregabaline bevatten. |
US20090176882A1 (en) | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
CN101462975B (zh) * | 2008-08-19 | 2012-07-25 | 宁波九胜创新医药科技有限公司 | 一种高纯度加巴喷丁的制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2611690A1 (de) | 1976-03-19 | 1977-09-22 | Goedecke Ag | Cyclische sulfonyloxyimide |
US4894476A (en) | 1988-05-02 | 1990-01-16 | Warner-Lambert Company | Gabapentin monohydrate and a process for producing the same |
US4960931A (en) | 1988-05-02 | 1990-10-02 | Warner-Lambert Company | Gabapentin mohohydrate and a process for producing the same |
FI107914B (fi) | 1989-08-25 | 2001-10-31 | Warner Lambert Co | Parannettu menetelmä syklisten aminohappoyhdisteiden valmistamiseksi ja menetelmässä käytettävä välituote |
DE3928183A1 (de) | 1989-08-25 | 1991-02-28 | Goedecke Ag | Lactamfreie cyclische aminosaeuren |
US5319135A (en) | 1989-08-25 | 1994-06-07 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
DE3928184A1 (de) | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte |
US5132451A (en) | 1989-08-25 | 1992-07-21 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
DE3928182A1 (de) | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von gabapentin |
US5084479A (en) | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
US5025035A (en) | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
IL119890A (en) * | 1996-12-24 | 2002-03-10 | Teva Pharma | Gabapentin form iii and preparation of gabapentin form ii |
ES2221385T3 (es) * | 1998-05-15 | 2004-12-16 | Warner-Lambert Company Llc | Preparaciones de gabapentina y pregabalina estabilizadas con aminoacidos y procedimiento para prepararlas. |
BR9910494B1 (pt) * | 1998-05-15 | 2011-11-01 | composições sólidas contendo derivados de ácido gama-aminobutìrico e processo para o seu preparo. | |
FR2781793B1 (fr) * | 1998-08-03 | 2001-07-20 | Prographarm Lab | Procede de fabrication de granules de gabapentine enrobes |
US6294198B1 (en) | 1999-08-24 | 2001-09-25 | Purepac Pharmaceutical Co. | Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same |
US7056951B2 (en) * | 2000-09-26 | 2006-06-06 | Mutual Pharmaceutical Co., Inc. | Stable solid dosage forms of amino acids and processes for producing same |
-
2001
- 2001-06-15 AT AT01946364T patent/ATE255891T1/de not_active IP Right Cessation
- 2001-06-15 US US09/880,854 patent/US6531509B2/en not_active Expired - Fee Related
- 2001-06-15 AU AU2001268426A patent/AU2001268426A1/en not_active Abandoned
- 2001-06-15 DK DK01946364T patent/DK1289364T3/da active
- 2001-06-15 TR TR2003/02296T patent/TR200302296T4/xx unknown
- 2001-06-15 DE DE60101476T patent/DE60101476T2/de not_active Revoked
- 2001-06-15 IL IL15339801A patent/IL153398A0/xx unknown
- 2001-06-15 DE DE1289364T patent/DE1289364T1/de active Pending
- 2001-06-15 ES ES01946364T patent/ES2193008T3/es not_active Expired - Lifetime
- 2001-06-15 PT PT01946364T patent/PT1289364E/pt unknown
- 2001-06-15 WO PCT/US2001/019100 patent/WO2001097612A1/en active IP Right Grant
- 2001-06-15 EP EP01946364A patent/EP1289364B1/en not_active Revoked
- 2001-06-15 CA CA002410867A patent/CA2410867C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1289364B1 (en) | 2003-12-10 |
ATE255891T1 (de) | 2003-12-15 |
DE60101476D1 (de) | 2004-01-22 |
ES2193008T1 (es) | 2003-11-01 |
EP1289364A4 (en) | 2003-08-06 |
ES2193008T3 (es) | 2004-07-01 |
DK1289364T3 (da) | 2004-04-13 |
EP1289364A1 (en) | 2003-03-12 |
DE1289364T1 (de) | 2003-09-18 |
DE60101476T2 (de) | 2004-05-27 |
US6531509B2 (en) | 2003-03-11 |
CA2410867A1 (en) | 2001-12-27 |
AU2001268426A1 (en) | 2002-01-02 |
IL153398A0 (en) | 2003-07-06 |
CA2410867C (en) | 2003-12-09 |
US20020061931A1 (en) | 2002-05-23 |
TR200302296T4 (tr) | 2004-02-23 |
WO2001097612A1 (en) | 2001-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1289364E (pt) | Gabapentina estavel contendo mais do que 20 ppm de iao cloreto | |
HN2002000152A (es) | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco | |
BR0211390A (pt) | Tratamento de infecções da unha com no | |
HK1045705A1 (zh) | 含水楊酸硅氧烷凝膠 | |
BR9914932A (pt) | Processo para a manufatura de uma composição de isotretinoìna, composição de isotretinoìna micronizada, forma de dosagem unitária para administração enteral e composição farmacêutica na forma de dosagem unitária | |
BR0210139A (pt) | Composições farmacêuticas | |
ATE245449T1 (de) | Pharmazeutische zusammensetzungen, die alkylamide von di- und tricarbonsäuren als gelierungsmittel enthalten | |
ES2184408T3 (es) | Sistema transdermico que contiene un antioxidante. | |
ES2130575T3 (es) | Composiciones inmunogenicas mejoradas contra la gastrina 17 humana. | |
AR041324A1 (es) | Composiciones suavizadoras de papel que contienen compuesto de amonio cuaternario y altos niveles de amina libre y productos de papel tisu suaves que comprenden las composiciones antes mencionadas | |
MXPA04001231A (es) | Composiciones topicas para aplicar y no enjuagar que contiene derivados seleccionados del acido pantotenico. | |
BRPI0418330A (pt) | composições sólidas de drogas de solubilidade baixa e poloxámeros | |
ES2187428T3 (es) | Composiciones que contienen agua mineral. | |
BR0300709A (pt) | Sal de perindopril e as composições farmacêuticas contendo o mesmo | |
CO5580729A2 (es) | Composiciones nutricionales que comprenden cistationina | |
BRPI0408848A (pt) | formulações orais de cladribine | |
DK1409449T3 (da) | Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse | |
DK0937043T3 (da) | Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater | |
BR9802803A (pt) | ação e composições farmacêuticas contendo os mesmos. | |
TW200505469A (en) | Glycyrrhizin containing pharmaceutical composition | |
IT1265647B1 (it) | Composizione farmaceutiche topiche per le allergie respiratorie | |
TR200100906T2 (tr) | Trombin inhibitörleri olarak benzamid türevleri | |
BR0112787A (pt) | Composições farmacêuticas contendo tobramicina e goma de xantano | |
PT1299114E (pt) | Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase | |
DE69602208D1 (de) | Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine |